Lung diseases among HIV infected patients admitted to the "Instituto Nacional del Torax" in Santiago, Chile;Enfermedades pulmonares en pacientes infectados con VIH hospitalizados en el Instituto Nacional del Tórax

Revista Medica de Chile

Volumn 133, Issue 5, 2005, Pages 517-524

  Chernilo S, Sara ^a   Trujillo V, Sergio ^a   Kahn Ch, Mariana ^a   Paredes P, Mónica ^a   Echevarría O, Ghislaine ^a   Sepúlveda L, Claudia ^a  

^a INSTITUTO NACIONAL DEL TÓRAX   (Chile)

Author keywords

Antiretroviral therapy; HIV; Lung diseases; Respiratory tract infections

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AIDS RELATED COMPLEX; CHILE; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILE; FEMALE; HIV INFECTIONS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 31144459475     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. MURRAY J, FELTON C, GARAY S ET AL. Pulmonary complications of the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 1682-8.
2. MILLER R. HIV-associated respiratory diseases. Lancet 1996; 348: 307-12.
3. AFESSA B, GREAVES W, GREEN W, OLOPONEIA L, SAXINGER C, FREDERICK W. Autopsy findings in HIV-infected inner-city patients. J Acquir Immune Defic Syndr 1992; 5: 132-6.
4. MASLIAH E, DETERESA R, MALLORY M, HANSEN L. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14: 69-74.
5. ROSEN M. Overview of pulmonary complications. Clinics in Chest Medicine 1996; 17: 621-31.
6. BATUNGWANAYO J, TAELMAN H, LUCAS S, BOGAERTS J, ALARD D, KAGAME A ET AL. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med 1994; 149: 1591-6.
7. WOLFF M, NORTHLAND R, SEGOVIA J, BELTRÁN C, VALDÉS M, ALBORNOZ M ET AL. Características clínicas e historia natural de la infección por virus de inmunodeficiencia humana. Estudio en una población chilena atendida en un centro piloto multiprofesional. Rev Méd Chile 1995; 123: 61-73.
8. WOLFF M, DIOMEDI A, MORALES O, BIDART T, DABANCH J, BUSTAMANTE C ET AL. Seguimiento prospectivo de una población infectada por VIH con y sin posibilidades de terapia anti-retroviral: impacto en sobrevida y complicaciones. Rev Méd Chile 2001; 129: 886-94.
9. SCHÖNFFELDT P, CHERNILO S, TRUJILLO S, SCHÖNFFELDT M, MAMANI R. Linfoma de las serosas asociado a Mycobacterium avium intracelular en un paciente con SIDA. Caso clínico. Rev Chil Enferm Respir 2002; 18: 267.
10. NIEDERMAN MS, MANDELL LA, ANZUETO A, BASS JB, BROUGHTON WA, CAMPBELL GD ET AL. Guidelines for the management of adults with communityacquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 2001; 163: 1730-54.
11. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996; 153: 1711-25.
12. ZAGOLÍN M, MORALES P, CHERNILO S. Compromiso pulmonar en pacientes VIH (+), experiencia del INERCYT, 1989-1997. Rev Chil Enferm Respir 1997; 13: 245.
13. Ministerio de Salud, Comisión Nacional del SIDA. Evaluación del impacto de una política pública: Ampliación del acceso a terapia antirretroviral en Chile. Rev Chil Infect 2003; 20: 277-84.
14. HOOVER DR, SAAH AJ, BACELLAR H, PHAIR J, DETELS R, ANDERSON R ET AL. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Eng J Med 1993; 329: 1922-6.
15. HIRSCHTICK RE, GLASSROTH J, JORDAN MC, WILCOSKY TC, WALLACE JM, KVALE PA ET AL. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Eng J Med 1995; 333: 845-51.
16. CORDERO E, PACHON J, RIVERO A, GIRÓN JA, GÓMEZMATEOS J, MERINO M ET AL. Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Am J Respir Crit Care Med 2000; 162: 2063-8.
17. Comisión Nacional de SIDA-CONASIDA. Ministerio de Salud. Panorama epidemiológico de la infección por VIH/SIDA en Chile-Año 2001. Rev Chil Infect 2002; 19: 245-61.
18. FERNÁNDEZ A, PULIDO F, PEÑA JM, SANZ M, LORENZO A, GONZÁLEZ J ET AL. Factores pronósticos de mortalidad durante el episodio de neumonía por Pneumocystis carinii en pacientes con infección por VIH. Rev Clin Esp 2002; 202: 416-20.
19. STOVER DE, WHITE DA, ROMANO PA, GELLENE RA, ROBESON WA. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med 1985; 429-37.
20. LEVINE SJ. Pneumocystis carinii Pulmonary Complications of HIV infection. Clinics in Chest Med 1996; 17: 665-95.
21. TUMBARELLO M, TACCONELLI E, DE GAETANO DONATI K, BERTAGNOLIO S, CATALDO M, PIRRONTI T ET AL. Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome. Eur Respir J 2001; 636-40.